Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 2
2017 2
2018 1
2020 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography.
Nilsson E, Sandgren K, Grefve J, Jonsson J, Axelsson J, Lindberg AK, Söderkvist K, Karlsson CT, Widmark A, Blomqvist L, Strandberg S, Riklund K, Bergh A, Nyholm T. Nilsson E, et al. Among authors: karlsson ct. Commun Med (Lond). 2023 Nov 9;3(1):164. doi: 10.1038/s43856-023-00394-7. Commun Med (Lond). 2023. PMID: 37945817 Free PMC article.
Quantifying the Effect of 3T Magnetic Resonance Imaging Residual System Distortions and Patient-Induced Susceptibility Distortions on Radiation Therapy Treatment Planning for Prostate Cancer.
Adjeiwaah M, Bylund M, Lundman JA, Karlsson CT, Jonsson JH, Nyholm T. Adjeiwaah M, et al. Among authors: karlsson ct. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):317-324. doi: 10.1016/j.ijrobp.2017.10.021. Epub 2017 Oct 20. Int J Radiat Oncol Biol Phys. 2018. PMID: 29229326 Free article.
Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy.
Wikström P, Bergström SH, Josefsson A, Semenas J, Nordstrand A, Thysell E, Crnalic S, Widmark A, Karlsson CT, Bergh A. Wikström P, et al. Among authors: karlsson ct. Cancers (Basel). 2022 Oct 23;14(21):5195. doi: 10.3390/cancers14215195. Cancers (Basel). 2022. PMID: 36358614 Free PMC article.
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.
Tannock IF, Fizazi K, Ivanov S, Karlsson CT, Fléchon A, Skoneczna I, Orlandi F, Gravis G, Matveev V, Bavbek S, Gil T, Viana L, Arén O, Karyakin O, Elliott T, Birtle A, Magherini E, Hatteville L, Petrylak D, Tombal B, Rosenthal M; VENICE investigators. Tannock IF, et al. Among authors: karlsson ct. Lancet Oncol. 2013 Jul;14(8):760-8. doi: 10.1016/S1470-2045(13)70184-0. Epub 2013 Jun 4. Lancet Oncol. 2013. PMID: 23742877 Clinical Trial.
14 results